• CREATES Act dropped but may still see progress

    The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act, which aims to address healthcare costs by facilitating the entry of lower-cost generic and biosimilar versions, may face challenges...

  • Pharma Technology Focus – Issue 70

    In this issue: A toolkit to enhance the user experience for life sciences, the problem of unapproved antibiotics in India, a new taxonomy for traditional Chinese medicine, inside Canada’s Centre...

  • Award-winning pharma packaging

    Pharmapack Europe has revealed the winners of the 2018 Pharmapack Awards. Elliot Gardner profiles the six winning packaging systems, from a motor-driven disposable auto-injector to an all-in-one contactless multidose delivery...

  • Pharma Technology Focus – Issue 69

    In this issue: The world’s pharma manufacturing hotspots, creating a universal flu vaccine, obstacles to improving the treatment of Alzheimer’s disease, the potential of growth drugs, detecting racemisation in drugs,...

  • Fentanyl: where did it all go wrong?

    Fentanyl, a powerful opioid painkiller developed in the early 1960s, has been an important part of pain management strategies for decades, but a recent explosion of fentanyl abuse has had...

  • What defines an over-the-counter drug?

    India has decided to rethink which medicines can and can’t be sold without prescriptions. These measures will finally create a definition for over the counter (OTC) drugs and possibly curb...

  • An HIV generic for the developing world

    Under a breakthrough pricing agreement, a generic antiretroviral for HIV/AIDS containing dolutegravir will become available across the developing world for just $75 per person per year. Abi Millar looks into...